MetP Pharma AG introduces nasal semaglutide with BrainDos Technology The intranasal delivery system offers hope in combating obesity-related healthcare burden MetP Pharma AG, leveraging the proprietary nose-to-brain drug delivery technology BrainDos in internal and external product development and manufacturing programs, recently announced its preclinical research results
The drug is similar to Ozempic, also made by Novo Nordisk, which is an injectable semaglutide used to treat type-2 diabetes
Certain plant-based remedies may have a role in improving particular PD symptoms
L-Carnitine helps transport fatty acids into the mitochondria, where they can be used for energy
Slows down the aging process
CJC-1295 / Ipamorelin peptide injections may be incorporated into wellness programs designed to support natural growth hormone signaling, recovery, and vitality